Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With Psoriasis
Journal of Drugs in Dermatology · 01.02.2024 · 23 (2) · 50-53
DOI: 10.36849/jdd.7928 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.01.2024. Verfasst von Leon Kircik und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatologic Agents, Psoriasis, Nicotinic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Kircik, L., & Jacobson, A. (2024). Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With Psoriasis. Journal of Drugs in Dermatology, 23(2), 50-53. https://doi.org/10.36849/jdd.7928
Vancouver
Kircik L, Jacobson A. Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With Psoriasis. Journal of Drugs in Dermatology. 2024;23(2):50-53. doi:10.36849/jdd.7928
BibTeX
@article{Kircik2024,
author = {Kircik, Leon and Jacobson, Abby},
title = {Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion With a Ceramide-Containing Moisturizer in Adults With Psoriasis},
journal = {Journal of Drugs in Dermatology},
year = {2024},
volume = {23},
number = {2},
pages = {50--53},
doi = {10.36849/jdd.7928}
}
EUVIMED